[ad_1] Media Credit: Donna Armstrong | Contributive Photo Editor More than 20 years after the opening of Mammovan, doctors have examined more than 37,000 women for breast cancer. In front of the …
Read More »
[ad_1] GW Hospital will be the first in the district to offer advanced software for stroke patients, according to a press release released Wednesday by the hospital. The hospital will soon use …
Read More »
[ad_1] After being assured that the Food and Drug Administration (FDA) and the Drug Enforcement Agency (DEA) accept GW Pharmaceuticals (NASDAQ: GWPH) plans to launch her marijuana-derived epilepsy drug, Epidiolex, in six …
Read More »
[ad_1] The Drug Enforcement Agency (DEA) awarded GW Pharmaceuticals& # 39; (NASDAQ: GWPH) epilepsy, Epidiolex, Appendix V status, its least restrictive classification. Decision allows GW Pharmaceuticals to start offering the only DEA-approved …
Read More »
[ad_1] Shares of GW Pharmaceuticals PLC hit a record high on Thursday after the medical marijuana company announced a new position of the Drug Enforcement Administration on its approved drug containing cannabidiol …
Read More »
[ad_1] The Drug Enforcement Administration reprogrammed Epidiolex, paving the way for GW Pharmaceuticals to sell the first FDA-approved drug derived from cannabis, but not allowing reclassification of all cannabidiol-based products.
Read More »
[ad_1] Scott Allen Reporter covering university sports D.C. Pro and local September 11 at 18:01 A couple of dramatic photos of George Washington's Smith Center's Jumbotron rocked to the side and relied …
Read More »
[ad_1] GW Pharmaceuticals plc GWPH a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics from its patented cannabinoid product platform, with its US subsidiary Greenwich Biosciences, announced on …
Read More »